company background image
ALTER logo

Theradiag ENXTPA:ALTER 株式レポート

最終価格

€1.26

時価総額

€16.4m

7D

-4.9%

1Y

-44.9%

更新

21 Dec, 2023

データ

会社財務

Theradiag SA

ENXTPA:ALTER 株式レポート

時価総額:€16.4m

ALTER 株式概要

Theradiag SA develops, manufactures, and markets in-vitro diagnostic products in France and internationally.

ALTER ファンダメンタル分析
スノーフレーク・スコア
評価0/6
将来の成長0/6
過去の実績2/6
財務の健全性4/6
配当金0/6

Theradiag SA 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめTheradiag
過去の株価
現在の株価€1.26
52週高値€2.39
52週安値€1.18
ベータ-0.27
11ヶ月の変化-5.97%
3ヶ月変化-43.75%
1年変化-44.86%
33年間の変化-51.91%
5年間の変化35.78%
IPOからの変化-77.74%

最新ニュース

Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Oct 04
Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Oct 03
Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Recent updates

Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Oct 04
Slammed 26% Theradiag SA (EPA:ALTER) Screens Well Here But There Might Be A Catch

Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Oct 03
Theradiag (EPA:ALTER) Might Have The Makings Of A Multi-Bagger

Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

Oct 26
Theradiag (EPA:ALTER) Is Carrying A Fair Bit Of Debt

株主還元

ALTERFR Medical EquipmentFR 市場
7D-4.9%-0.9%-1.9%
1Y-44.9%23.7%1.9%

業界別リターン: ALTER underperformed the French Medical Equipment industry which returned 5.2% over the past year.

リターン対市場: ALTER underperformed the French Market which returned 12.7% over the past year.

価格変動

Is ALTER's price volatile compared to industry and market?
ALTER volatility
ALTER Average Weekly Movement9.7%
Medical Equipment Industry Average Movement5.8%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.6%
10% least volatile stocks in FR Market2.1%

安定した株価: ALTER's share price has been volatile over the past 3 months.

時間の経過による変動: ALTER's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
198661Simon Davierewww.theradiag.com

Theradiag SA 基礎のまとめ

Theradiag の収益と売上を時価総額と比較するとどうか。
ALTER 基礎統計学
時価総額€16.44m
収益(TTM)€421.92k
売上高(TTM)€13.51m

39.0x

PER(株価収益率

1.2x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
ALTER 損益計算書(TTM)
収益€13.51m
売上原価€7.24m
売上総利益€6.26m
その他の費用€5.84m
収益€421.92k

直近の収益報告

Jun 30, 2023

次回決算日

該当なし

一株当たり利益(EPS)0.032
グロス・マージン46.37%
純利益率3.12%
有利子負債/自己資本比率17.1%

ALTER の長期的なパフォーマンスは?

過去の実績と比較を見る